Psychedelic substances have been demonstrated to interact with a variety of neurotransmitter pathways, including those involving serotonin, acetylcholine, norepinephrine, and dopamine. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of psychedelic substances. Further, experts believe that psychedelics, at appropriate doses, can be used to address some of the serious psychological implications associated with the COVID-19 pandemic.
To order this 250+ page report, which features 120+ figures and 135+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
The over USD 6.5 billion (by 2030) financial opportunity within the psychedelic therapeutics market has been analyzed across the following segments:
- Target Disease Indication
- Anxiety and Depression
- Trauma
- Pain Disorder
- Sleep related Disorder
- Origin of Psychedelic Substance
- Natural
- Synthetic
- Type of Psychedelic Substance
- Gamma-hydroxybutyrate
- Ketamine
- MDMA
- Psilocybin
- Route of Administration
- Oral
- Intranasal
- Sublingual
- Key Geographies
- North America
- Europe
- Asia-Pacific
The Global Psychedelic Therapeutics Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:
- Celon Pharma
- iX Biopharma
- MAPS Public Benefit
- MindMed
- Janssen Pharmaceuticals
- Jazz Pharmaceutical
Key companies covered in the - https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market/request-sample.html
Table of Contents
- Preface
2. Executive Summary
Introduction
- Market Landscape: Psychedelic Therapeutics
- Company Profiles
- Clinical Trial Analysis
- Clinical Trial Site Analysis
- Key Opinion Leader (KOL) Analysis
- Academic Grants Analysis
- Partnerships and Collaborations
- Mergers and Acquisitions
- Market Forecast and Opportunity Analysis
- Concluding Remarks
- Executive Insights
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To purchase a copy, please visit - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Other Recent Offerings
- Global Preventive Vaccines Market, 2020-2030
- Endocannabinoid System Targeted Therapeutics Market, 2019-2030
- Antibody Contract Manufacturing Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
